Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Switching to Preservative-Free ZOLYMBUS on Dry Eye Symptoms in Glaucoma Patients
NCT07845357Phase 4Not yet recruiting
- Sponsor
- Southern College of Optometry
- Start
- Oct 2026
- Primary completion
- Feb 2027
01
Overview
Phase 4, open-label, single-arm trial of bimatoprost in Glaucoma and ocular hypertension, sponsored by Southern College of Optometry. Primary endpoint: Change in Eye Dryness Visual Analog Scale Score at 3 months. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT07845357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845357.